[1]Locationinpatent:experimentalpartJin,Chuanfei;Liang,Yong-Ju;He,Hongwu;Fu,Liwu[EuropeanJournalofMedicinalChemistry,2011,vol.46,#1,p.429-432]
[1]EuropeanJournalofMedicinalChemistry,2011,vol.46,p.429-432
387358-42-1
107718-34-3
102408-27-5 | 3H-Imidazo[4,5-f]quinolin-2-amine, N,N,3-trimethyl- | AA0007B3 | MFCD00468066
10257-28-0 | D-Galactose | AA0007OI | MFCD00151230
1026962-68-4 | 6-Bromo-2-fluoro-3-(trifluoromethyl)benzoic acid | AA00082E | MFCD21365092
1134691-04-5 | Benzenepropanoic acid, 4-(dimethylamino)-, hydrochloride (1:1) | AA0008LT | MFCD06797873
1137109-21-7 | 3-(2-Maleimidoethylcarbonyl)amino(peg6)propionic acid N-Hydroxysuccinimide ester | AA0009BZ | MFCD11041093
113975-32-9 | N-(4-Iodo-pyridin-3-yl)-2,2-dimethyl-propionamide | AA000A59 | MFCD06659003
1142194-28-2 | 4-Bromo-N,N-diethylpyridin-2-amine | AA000ARP | MFCD11869617
1160246-72-9 | tert-Butyl 2-oxo-1,7-diazaspiro[4.4]nonane-7-carboxylate | AA000BBS | MFCD12198506
116140-49-9 | 3-Methylpiperidine-3-carboxylic acid | AA000BND | MFCD12024776
116371-67-6 | Gemcitabine monophosphate | AA000C8X | MFCD18252926